824 related articles for article (PubMed ID: 33202963)
1. Insights into Potential Targets for Therapeutic Intervention in Epilepsy.
Zavala-Tecuapetla C; Cuellar-Herrera M; Luna-Munguia H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202963
[TBL] [Abstract][Full Text] [Related]
2. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.
Kaminski RM; Rogawski MA; Klitgaard H
Neurotherapeutics; 2014 Apr; 11(2):385-400. PubMed ID: 24671870
[TBL] [Abstract][Full Text] [Related]
3. Role of mTOR inhibitors in epilepsy treatment.
Sadowski K; Kotulska-Jóźwiak K; Jóźwiak S
Pharmacol Rep; 2015 Jun; 67(3):636-46. PubMed ID: 25933981
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin signaling as a potential target for novel epilepsy therapies.
Hodges SL; Lugo JN
Epilepsy Res; 2018 Oct; 146():9-16. PubMed ID: 30053675
[TBL] [Abstract][Full Text] [Related]
5. Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy?
Hartz AM; Notenboom S; Bauer B
Drug News Perspect; 2009 Sep; 22(7):393-7. PubMed ID: 19890496
[TBL] [Abstract][Full Text] [Related]
6. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
Löscher W; Klein P
CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
[TBL] [Abstract][Full Text] [Related]
7. TRPV1: a potential target for antiepileptogenesis.
Fu M; Xie Z; Zuo H
Med Hypotheses; 2009 Jul; 73(1):100-2. PubMed ID: 19328632
[TBL] [Abstract][Full Text] [Related]
8. Candidate drug targets for prevention or modification of epilepsy.
Varvel NH; Jiang J; Dingledine R
Annu Rev Pharmacol Toxicol; 2015; 55():229-47. PubMed ID: 25196047
[TBL] [Abstract][Full Text] [Related]
9. Pannexin-1 channels contribute to seizure generation in human epileptic brain tissue and in a mouse model of epilepsy.
Dossi E; Blauwblomme T; Moulard J; Chever O; Vasile F; Guinard E; Le Bert M; Couillin I; Pallud J; Capelle L; Huberfeld G; Rouach N
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848662
[TBL] [Abstract][Full Text] [Related]
10. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
Rogawski MA; Donevan SD
Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
[TBL] [Abstract][Full Text] [Related]
11. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
[TBL] [Abstract][Full Text] [Related]
12. Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies.
van Vliet EA; Aronica E; Vezzani A; Ravizza T
Neuropathol Appl Neurobiol; 2018 Feb; 44(1):91-111. PubMed ID: 28977690
[TBL] [Abstract][Full Text] [Related]
13. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
Löscher W
Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
[TBL] [Abstract][Full Text] [Related]
14. Zinc signaling and epilepsy.
Doboszewska U; Młyniec K; Wlaź A; Poleszak E; Nowak G; Wlaź P
Pharmacol Ther; 2019 Jan; 193():156-177. PubMed ID: 30149099
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy.
Tabassum S; Shorter S; Ovsepian SV
J Mol Med (Berl); 2024 Jun; 102(6):761-771. PubMed ID: 38653825
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy: key experimental therapeutics in early clinical development.
Steriade C; French J; Devinsky O
Expert Opin Investig Drugs; 2020 Apr; 29(4):373-383. PubMed ID: 32172604
[No Abstract] [Full Text] [Related]
17. Role of the mTOR signaling pathway in epilepsy.
Meng XF; Yu JT; Song JH; Chi S; Tan L
J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic targets for epilepsy intervention.
Kambli L; Bhatt LK; Oza M; Prabhavalkar K
Seizure; 2017 Oct; 51():27-34. PubMed ID: 28772199
[TBL] [Abstract][Full Text] [Related]
19. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
Löscher W; Potschka H; Sisodiya SM; Vezzani A
Pharmacol Rev; 2020 Jul; 72(3):606-638. PubMed ID: 32540959
[TBL] [Abstract][Full Text] [Related]
20. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
